Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study
Clinical trial NCT06021366 · COMPLETED
Trial details
- NCT number
- NCT06021366
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-07
- Primary completion
- 2022-08-29
- Enrollment
- 2089
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.